- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/22 - Hormones
Patent holdings for IPC class A61K 38/22
Total number of patents in this class: 2587
10-year publication summary
|
205
|
243
|
233
|
214
|
218
|
175
|
182
|
173
|
132
|
38
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
82 |
| Novo Nordisk A/S | 2324 |
42 |
| Eli Lilly and Company | 3645 |
33 |
| Hanmi Pharm. Co., Ltd. | 546 |
31 |
| Mayo Foundation for Medical Education and Research | 2981 |
30 |
| Rani Therapeutics, LLC | 184 |
27 |
| MannKind Corporation | 531 |
26 |
| The Regents of the University of California | 18943 |
25 |
| Transdermal Biotechnology, Inc. | 68 |
24 |
| Adocia | 143 |
22 |
| Janssen Pharmaceutica N.V. | 3839 |
21 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
20 |
| BioMarin Pharmaceutical Inc. | 368 |
20 |
| Sanofi | 3836 |
20 |
| Zealand Pharma A/S | 211 |
19 |
| Amylin Pharmaceuticals, Inc. | 58 |
18 |
| University of Florida Research Foundation, Inc. | 3883 |
17 |
| Igisu Co., Ltd | 22 |
17 |
| University of Miyazaki | 133 |
17 |
| Ascendis Pharma Growth Disorders A/S | 36 |
17 |
| Other owners | 2059 |